Acorda Therapeutics, Inc. (ACOR) News
Filter ACOR News Items
ACOR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest ACOR News From Around the Web
Below are the latest news stories about ACORDA THERAPEUTICS INC that investors may wish to consider to help them evaluate ACOR as an investment opportunity.
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call TranscriptAcorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Welcome to Acorda Therapeutics Third Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request. […] |
Acorda Therapeutics Reports Third Quarter 2023 Financial ResultsPEARL RIVER, N.Y., November 13, 2023--Acorda Therapeutics Reports Third Quarter 2023 Financial Results |
Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023PEARL RIVER, N.Y., November 06, 2023--Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023 |
Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®PEARL RIVER, N.Y., November 06, 2023--Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA® |
Acorda Therapeutics (ACOR): A Comprehensive Analysis of Its Market ValueUnveiling the Intrinsic Value of Acorda Therapeutics |
Acorda Therapeutics Reports Second Quarter 2023 Financial ResultsPEARL RIVER, N.Y., August 08, 2023--Acorda Therapeutics Reports Second Quarter 2023 Financial Results |
Acorda Therapeutics Announces Launch of New INBRIJA® Campaign: "For The Fighters™"PEARL RIVER, N.Y., August 02, 2023--Acorda Therapeutics Announces Launch of New INBRIJA® Campaign: "For The FightersTM" |
Acorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023PEARL RIVER, N.Y., August 01, 2023--Acorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023 |
Tom Burns Elected to the Acorda Therapeutics Board of DirectorsPEARL RIVER, N.Y., June 28, 2023--Tom Burns Elected to the Acorda Therapeutics Board of Directors |
Acorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementPEARL RIVER, N.Y., June 26, 2023--Acorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement |